Improvement of the quality of care through standardized documentatio

Recruiting

• Conditions: C61; C67; C64; C62; C66; C60; C68; C65; Malignant neoplasm of prostate; Malignant neoplasm of bladder

• Registration Number: DRKS00015762
• Lead Sponsor: d-uo Deutsche Uro-OnkologenInteressenverband zur Qualitätssicherung in der Uro-Onkologie in Deutschland e.V.Geschäftsstelle Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-10-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 999999

Inclusion Criteria

Men and Women with verified urological cancer

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall survival (OS) and Cancer-specific survival (CS) stratified for guideline adherence

Secondary Outcome Measures

Name	Time	Method
umber of documented patients per quarter / year and comparison with data on incidence and prevalence (Robert Koch Institute, cancer registry), recording of drug interactions / side effects for oncological drugs per quarter / year and comparison with the respective registration studies, recording of nicotine abuse and occupational noxae per new diagnosis of urothelial carcinoma, recording the number of patients reported to the second opinion centers and the number of subsequent therapy modifications. comparison of follow-up care in the practices of the association for quality assurance in<br>Uro-Oncology in Germany e.V. with guideline recommendations. Frequency of use of Active Surveillance and Fertility Protection.